The biology and diagnostic applications of cadherins in neoplasia: A review

Pathology

Volumn 35, Issue 2, 2003, Pages 101-105

  Wood, Benjamin A ^b   Leong, Anthony S Y ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

^b NONE

Author keywords

Cadherin; E cadherin; Immunohistochemistry; Review

Indexed keywords

ACTIN; CADHERIN; CATENIN; CELL ADHESION MOLECULE; CYCLIN DEPENDENT KINASE INHIBITOR; NERVE CELL ADHESION MOLECULE; P CADHERIN; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN;

ANTIBODY LABELING; CANCER DIAGNOSIS; CANCER INVASION; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL STRUCTURE; CELL TRANSFORMATION; CELL TYPE; CORRELATION ANALYSIS; CYTOSKELETON; GASTRULATION; GROWTH CONE; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; MOLECULAR GENETICS; MORPHOGENESIS; MORPHOLOGY; NEOPLASM; NONHUMAN; PHENOTYPE; PROGNOSIS; PROMOTER REGION; PROTEIN DEFECT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0037951699     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020307588     Document Type: Review

References (53)

1. Beavon I, Regulation of E-caderin: does hypoxia initiate the metastatic cascade? Mol Pathol 1999; 52: 179-88.
2. Leong AS-Y, Leong FJW-M. What we need to know about cancer genes. Diagn Cytopathol 1998; 18: 33-40.
3. Yagi T, Takeichi M. Cadherin superfamily genes: functions, genomic organization and neurologic diversity. Genes Devel 2000; 14: 1169-80.
4. Nollet F, Kools P, van Roy F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 2000; 299: 551-72.
5. Alberts B, Bray D, Lewis J, et al. Molecular Biology of the Cell. New York: Garland Publishing, 1994; 963-71.
6. Steinberg M, McNutt P. Cadherins and their connections: adhesion molecules have broader functions. Curr Opin Cell Biol 1999; 17: 554-60.
7. Blaschuk O, Sulliavan R, David S, et al. Identification of a cadherin cell adhesion recognition sequence. Devel Biol 1990; 139: 227-9.
8. 2+ dependence and muatational analysis reveal molecular details of E-cadherin homoassociation. EMBO J 1999; 18: 1738-47.
9. Frenette P, Wagner D. Adhesion molecules - Part 1. N Engl J Med 1996; 334: 1526-9.
10. Ilyas M, Tomlinson I. The interactions of APC, E cadherin and β-catenin in tumour development and progression. J Pathol 1997; 182: 128-37.
11. Huber O, Bierkamp C, Kemler R. Cadherins and catenins in development. Curr Opin Cell Biol 1996; 8: 685-91.
12. Yap A, Brieher W, Pruschy M, et al. Lateral clustering of the adhesive ectodomain: a fundamental determinant of cadherin function. Curr Biol 1997; 7: 308-15.
13. Katz B, Levenberg S, Yamada K, et al. Modulation of cell-cell adherins junctions by surface clustering of the N-cadherin cytoplasmic tail. Exp Cell Res 1998; 243: 415-24.
14. Brieher W, Yap A, Gumbiner B. Lateral dimerization is required for the homophilic binding activity of C-cadherin. J Cell Biol 1996; 135: 487-96.
15. Steinberg M, Takeichi M. Experimental specification of cell sorting, tissue spreading and specific spatial patterning by quantitative differences in cadherin expression. Proc Natl Acad Sci USA 1994; 91: 206-9.
16. Gumbiner B. Regulation of cadherin adhesive activity. J Cell Biol 2000; 148: 399-404.
17. Daniel J, Reynolds A. Tyrosine phosphorylation and cadherin/catenin function. Bioessays 1997; 19: 883-91.
18. Vestweber D, Gossler A, Boller K, et al. Expression and distribution of cell adhesion molecule uvomorulin in mouse preimplantation embryos. Devel Biol 1987; 124: 451-6.
19. Kirchner T, Brabletz T. Tumour patterning: analogies of neoplastic morphogenesis with embryogenesis. Verb Dtsch Ges Pathol 2000; 84: 22-7.
20. Tepass U, Truong K, Godt D, et al. Cadherins in embryonic and neural morphogenesis. Nat Rev Mol Cell Biol 2000; 1: 91-100.
21. Rietmacher D, Brinkman V, Birchmeir C. A targetted mutation in the mouse E-cadherin gene results in defective pre-implantation development. Proc Natl Acad Sci USA 1995; 48: 143-6.
22. Dogan A, Wang Z, Spencer J. E-cadherin expression in intestinal epithelium. J Clin Pathol 1995; 48: 143-6.
23. Jankowski J, Bedford F, Boulton R, et al. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Lab Invest 1998; 78: 1155-67.
24. St Croix B, Sheehan C, Rak J, et al. E-cadherin dependent growth inhibition is mediated by the cyclin dependent kinase inhibitor p27 (KIPI). J Cell Biol 1998; 142: 557-71.
25. Bailey T, Biddlestone L, Shepard N, et al. Altered cadherin and catenin complexes in the Barrett's oesophagus-dysplasia-adenocarcinoma sequence:correlation with disease progression and differentiation. Am J Pathol 1998; 152: 135-44.
26. Christofori G. The role of the cell-cell adhesion molecule E-cadherin as a tumour supressor gene. Trends Biochem Sci 1999; 24: 73-6.
27. Birchmeier W, Hulsken J, Behrens J. Adjerins junctions proteins in tumour progression. Cancer Surv 1995; 24: 129-40.
28. Tsuda H, Zhang W, Shimosato Y, et al. Allelle loss on chromosome 16 asssociated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 691-4.
29. Winjhoven B, de Both N, Van Dekhen H. E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus. Br J Cancer 1999; 80: 1652-7.
30. Richards F, McKee S, Rajpar M, et al. Germline E-cadherin mutations predispose to familial gastric and colorectal cancer. Hum Mol Genet 1999; 4: 607-10.
31. Huntsman D, Craneiro F, Lewis F, et al. Early gastric cancer in young asymptomatic carriers of germline E-cadherin mutations. N Engl J Med 2001; 394: 1904-9.
32. Sanders D, Perry I, Hardy R, et al. Aberrant P-cadherin expression is a feature of clonal expansion in the gastrointestinal tract associated with repair and neoplasia. J Pathol 2000; 190: 526-30.
33. Williams H, Sanders D, Jankowski J, et al. Expression of cadherins and catenins during epithelial dysplasia and oral squamous cell carcinoma. J Oral Pathol Med 1998; 27: 308-17.
34. Sanders D, Bruton R, Danton S, et al. Sequential changes in cadherin-catenin complexes in heterogeneity of primary oesophageal squamous carcinoma. Int J Cancer (Pred Oncol) 1998; 27: 573-9.
35. Makrigiannakis A, Coukos G, Christofidou-Solomidou M, et al. N-cadherin-mediated human granulosa cell adhesion prevents apoptosis. Am J Pathol 1999; 154: 1391-406.
36. Takeichi M. Cadherins in cancer: implication for invasion and metastasis. Curr Opin Cell Biol 1993; 5: 806-11.
37. Vleminckx K, Vakaet L, Mareel M, et al. Genetic manipulation of E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol 1994; 174: 243-8.
38. Pignatelli M, Ansari T, Gunter P, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol 1994; 174: 243-8.
39. Bukholm I, Nesland J, Karasen R, et al. E-cadherin and alpha-, beta- and gamma- catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 1998; 185: 262-6.
40. Mbalviele G, Dunstan C, Sasaki A, et al. E-cadherin expression in human breast cancer cells supresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 1996; 56: 4063-70.
41. Siitonen S, Koonen J, Helin H, et al. Reduced E-cadherin expression is associated with invasiveness and unfavourable prognosis in breast cancer. Am J Clin Pathol 1996; 105: 394-402.
42. Lipponen P, Saaelainan E, Ji H, et al. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994; 174: 101-9.
43. Franchi A, Gallo O, Boddi V, et al. Prediction of occult lymph node metastasis in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1 and E-cadherin immunohistochemical determination. Clin Cancer Res 1996; 2: 1801-8.
44. Sormunen R, Leong A S-Y, Vaaraniemi J, et al. Immunolocalization of the fodrin, E-cadherin and β-catenin adhesion complex in infiltrating ductal carcinoma of the breast - comparison with an in vitro model. J Pathol 1999; 187: 416-23.
45. Wijnhoven B, Dinjens W, Pignatelli M. E-cadherin-catenin cell adhesion complex and human cancer. Br J Surg 2000; 87: 992-1005.
46. Rosen P. Rosen's Breast Pathology. 2nd ed. Philadelphia: Lippincott, Williams and Wilkins, 2001.
47. Han A, Soler A, Knudson K, et al. Diferential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinoma in formalin fixed paraffin embedded tissues. Hum Pathol 1997; 28: 641-5.
48. Davidson B, Nielsen S, Christensen J, et al. The role of desmin and N cadherin in effusion cytology. Am J Surg Pathol 2001; 25: 1405-12.
49. Battifora H. The pleura. In: Sternberg S, Antonioli D, Carter D, et al., editors. Diagnostic surgical pathology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 1999.
50. Leong AS-Y, Vernon-Roberts E. The immunohistochemistry of malignant mesothelioma. Pathol Annu 1994; 29 (Pt 2): 157-79.
51. Griffiths T, Brotherick J, Bishop R, et al. Cell adhesion molecules in bladder cancer: soluble E-cadherin correlates with predictors of recurrence. Br J Cancer 1996; 74: 579-84.
52. Gadducci A, Ferdeghni M, Cosio S, et al. Pre-operative serum E-cadherin assay in patients with ovarian carcinoma. Anticancer Res 1999; 19: 769-72.
53. Gofuku, Shiozaki H, Doki Y, et al. Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. Br J Cancer 1998, 78: 1095-101.